Pulmonary Rifampicin- and Isoniazid-Resistant Tuberculosis

DBCOND0154353Gram-Positive Bacterial Infections

Pulmonary Rifampicin- and Isoniazid-Resistant Tuberculosis is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Gram-Positive Bacterial Infections
Indicated drugs: Pretomanid

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for Pulmonary Rifampicin- and Isoniazid-Resistant Tuberculosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account